ImportRefusal LogoImportRefusal

NIDEK Co., Ltd.

⚠️ Moderate Risk

FEI: 3002807715 • Gamagoori, Aichi • JAPAN

FEI

FEI Number

3002807715

📍

Location

Gamagoori, Aichi

🇯🇵

Country

JAPAN
🏢

Address

34-14, Hiroishi-Cho, Gamagoori, Aichi, Japan

Moderate Risk

FDA Import Risk Assessment

34.2
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
6
Unique Violations
6/20/2017
Latest Refusal
1/29/2004
Earliest Refusal

Score Breakdown

Violation Severity
59.0×40%
Refusal Volume
33.5×30%
Recency
0.0×20%
Frequency
5.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3412×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

5082×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

1261×

FAILS STD

The article appears to be a device which is subject to a performance standard established under Section 514 and does not appear to be in all respects in conformity with such standard.

2371×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

23801×

NO PMA/PDP

The article appears to be a class III dev.w/o an approved applic. for premarket approval, and/or a notice of completion of product development protocol filed per section 515(b) or exempt per sect.520(g)(1).

Refusal History

DateProductViolationsDivision
6/20/2017
86HQFLASER, OPHTHALMIC
126FAILS STD
Division of Southeast Imports (DSEI)
8/18/2015
86LZSLASER, SYSTEM, EXCIMER
2380NO PMA/PDP
Cincinnati District Office (CIN-DO)
4/3/2015
86HJLLENS, CONDENSING, DIAGNOSTIC
118NOT LISTED
Florida District Office (FLA-DO)
6/10/2013
86MYCOPHTHALMOSCOPE, LASER, SCANNING
341REGISTERED
Florida District Office (FLA-DO)
9/13/2010
86HQRAPPARATUS, CAUTERY, RADIOFREQUENCY, AC-POWERED
118NOT LISTED
508NO 510(K)
Division of Southeast Imports (DSEI)
5/14/2008
86LZSLASER, SYSTEM, EXCIMER
237NO PMA
Florida District Office (FLA-DO)
1/29/2004
80LDQDEVICE, GENERAL MEDICAL
118NOT LISTED
341REGISTERED
508NO 510(K)
Florida District Office (FLA-DO)

Frequently Asked Questions

What is NIDEK Co., Ltd.'s FDA import refusal history?

NIDEK Co., Ltd. (FEI: 3002807715) has 7 FDA import refusal record(s) in our database, spanning from 1/29/2004 to 6/20/2017.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. NIDEK Co., Ltd.'s FEI number is 3002807715.

What types of violations has NIDEK Co., Ltd. received?

NIDEK Co., Ltd. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about NIDEK Co., Ltd. come from?

All FDA import refusal data for NIDEK Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.